Royalty Pharma Plc (RPRX)

45.41 -0.27 (-0.59%) USD  |  NASDAQ  |  Mar 06, 16:00
45.42 +0.01 (+0.02%) After-Hours: 20:00
More

Royalty Pharma SG&A Expense (TTM) : 573.21M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for RPRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Zymeworks, Inc. 46.08M
PTC Therapeutics, Inc. 347.14M
Johnson & Johnson 23.68B
Veru, Inc. 18.80M
Incyte Corp. 1.376B